152 related articles for article (PubMed ID: 20383188)
61. [Clinical evaluation on differential quantitation of human chorionic gonadotropin in testicular cancer].
Nakamura K; Deguchi N; Nakanoma T; Hagiwara M; Tazaki H; Hata J
Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):408-13. PubMed ID: 1694252
[TBL] [Abstract][Full Text] [Related]
62. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
Javadpour N; Soares T
Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
[TBL] [Abstract][Full Text] [Related]
63. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
64. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
[TBL] [Abstract][Full Text] [Related]
65. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
66. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
Uysal Z; Bakkaloğlu M
Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
[TBL] [Abstract][Full Text] [Related]
67. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
de Bruijn HW; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Marrink J; Ockhuizen T
Cancer; 1985 Feb; 55(4):829-35. PubMed ID: 2578303
[TBL] [Abstract][Full Text] [Related]
68. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
Bruns F; Raub M; Schaefer U; Micke O
Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
[TBL] [Abstract][Full Text] [Related]
69. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.
Rotmensch S; Cole LA
Lancet; 2000 Feb; 355(9205):712-5. PubMed ID: 10703803
[TBL] [Abstract][Full Text] [Related]
70. Serum markers in germ cell neoplasms.
Bartlett NL; Freiha FS; Torti FM
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
[TBL] [Abstract][Full Text] [Related]
71. Chemotherapy of disseminated seminoma.
Einhorn LH; Williams SD
Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
[TBL] [Abstract][Full Text] [Related]
72. False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors.
Germa JR; Arcusa A; Casamitjana R
Cancer; 1987 Nov; 60(10):2489-93. PubMed ID: 2444325
[TBL] [Abstract][Full Text] [Related]
73. Thyrotoxicosis in a male patient associated with excess human chorionic gonadotropin production by germ cell tumor.
Goodarzi MO; Van Herle AJ
Thyroid; 2000 Jul; 10(7):611-9. PubMed ID: 10958315
[TBL] [Abstract][Full Text] [Related]
74. The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma.
Paus E; Fosså SD; Risberg T; Nustad K
Br J Urol; 1987 Jun; 59(6):572-7. PubMed ID: 3690188
[TBL] [Abstract][Full Text] [Related]
75. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Morris MJ; Bosl GJ
J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
[TBL] [Abstract][Full Text] [Related]
76. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
77. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review.
Nicholson BD; Jones NR; Protheroe A; Joseph J; Roberts NW; Van den Bruel A; Fanshawe TR
Cancer Epidemiol; 2019 Apr; 59():15-21. PubMed ID: 30658216
[TBL] [Abstract][Full Text] [Related]
78. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy.
Eastham JA; Wilson TG; Russell C; Ahlering TE; Skinner DG
Urology; 1994 Jan; 43(1):74-80. PubMed ID: 7506856
[TBL] [Abstract][Full Text] [Related]
79. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
[TBL] [Abstract][Full Text] [Related]
80. Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.
Mann K; Karl HJ
Cancer; 1983 Aug; 52(4):654-60. PubMed ID: 6305481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
